lamivudine
MOH-02
Approved small_molecule completed
Quick answer
lamivudine for Compensated Chronic Hepatitis B is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Compensated Chronic Hepatitis B
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed